- Home
- LDI vs CATX Comparison
LDI vs CATX Comparison
Compare LDI & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LDI
- CATX
- Stock Information
- Founded
- LDI 2010
- CATX 1983
- Country
- LDI United States
- CATX United States
- Employees
- LDI N/A
- CATX N/A
- Industry
- LDI Finance: Consumer Services
- CATX Medical/Dental Instruments
- Sector
- LDI Finance
- CATX Health Care
- Exchange
- LDI Nasdaq
- CATX Nasdaq
- Market Cap
- LDI 221.2M
- CATX 182.9M
- IPO Year
- LDI 2021
- CATX N/A
- Fundamental
- Price
- LDI $1.15
- CATX $2.34
- Analyst Decision
- LDI Sell
- CATX Strong Buy
- Analyst Count
- LDI 3
- CATX 10
- Target Price
- LDI $1.98
- CATX $13.89
- AVG Volume (30 Days)
- LDI 721.5K
- CATX 619.9K
- Earning Date
- LDI 05-06-2025
- CATX 05-12-2025
- Dividend Yield
- LDI N/A
- CATX N/A
- EPS Growth
- LDI N/A
- CATX N/A
- EPS
- LDI N/A
- CATX N/A
- Revenue
- LDI $1,039,763,000.00
- CATX $1,454,000.00
- Revenue This Year
- LDI $32.81
- CATX N/A
- Revenue Next Year
- LDI $16.35
- CATX N/A
- P/E Ratio
- LDI N/A
- CATX N/A
- Revenue Growth
- LDI 15.41
- CATX 1.40
- 52 Week Low
- LDI $1.01
- CATX $1.60
- 52 Week High
- LDI $3.23
- CATX $19.10
- Technical
- Relative Strength Index (RSI)
- LDI 48.63
- CATX 51.17
- Support Level
- LDI $1.02
- CATX $2.18
- Resistance Level
- LDI $1.21
- CATX $2.65
- Average True Range (ATR)
- LDI 0.08
- CATX 0.16
- MACD
- LDI 0.02
- CATX 0.02
- Stochastic Oscillator
- LDI 59.52
- CATX 56.25
About LDI loanDepot Inc.
loanDepot Inc provides nonbank consumer lending solutions for individuals in the United States. It offers personal, residential home, home refinancing, mortgage and home equity loans. It also provides online mortgage loans for refinancing and home purchases. It serves customers through distribution channels, including consumer direct centres, retail branches, wholesale centres, and consumer finance and servicing centres in the United States. It competes with commercial banks and financial institutions.
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.